Impact of Conventional Treatments and Clinical Variables on Thyroid Cancer
NCT05752604 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2025-08-03
Summary
DTC has a generally favorable prognosis. The possibility to discriminate between patients with aggressive tumors and those with a more indolent behavior may reduce the need for unnecessary treatments. Aim of this observational study is to evaluate how anamnestic, clinical, and histopathological variables may influence the outcome of the enrolled patients, both regarding morbidity and mortality and in terms of therapeutic choices. The study aims to evaluate the prognostic impact of the therapeutic interventions in terms of efficacy and regarding the appearance of adverse events.
Conditions
Sponsors & Collaborators
-
Istituto Auxologico Italiano
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-12
- Primary Completion
- 2032-03-08
- Completion
- 2042-03-08
Countries
- Italy
Study Locations
More Related Trials
-
The Initial Management in Patients With Differentiated Thyroid Cancer in the Real World in China
NCT04857086 ·Status: UNKNOWN
-
Evaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology
NCT06779747 ·Status: RECRUITING
-
Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up
NCT04290663 ·Status: RECRUITING ·Phase: PHASE3
-
Predictive Factors of Clinical, Laboratory and Imaging Findings Routinely Used in Diagnosing Thyroid Cancer
NCT01074684 ·Status: COMPLETED
-
Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma
NCT06087068 ·Status: RECRUITING ·Phase: PHASE2
-
Thyroid Hormone Replacement After Radio Iodine: Value and Efficacy
NCT06647602 ·Status: NOT_YET_RECRUITING
-
Observational Study Analysing the Transcriptome and Mutational Status of Thyroid Carcinomas of Follicular Origin with Different Degrees of Malignancy
NCT06878534 ·Status: RECRUITING
-
A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer
NCT05733013 ·Status: RECRUITING
-
Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer
NCT00094055 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Endocrine Disruptors in Thyroid Cancer
NCT05747365 ·Status: RECRUITING
-
Observational Study on Thyroid Tumors and EvaLuation of the roLe of New pOntential Predictive/Prognostic Factors
NCT07064369 ·Status: ENROLLING_BY_INVITATION
-
Initial Management in Patients With Differentiated Thyroid Cancer in the Real World in China
NCT02638077 ·Status: UNKNOWN
-
Treatment for Patients With Metastatic Thyroid Cancer
NCT00176748 ·Status: COMPLETED ·Phase: PHASE2
-
Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment
NCT03624751 ·Status: ACTIVE_NOT_RECRUITING
-
Method of Endogenous TSH Stimulation in the Follow-up of Differentiated Thyroid Cancer
NCT01840332 ·Status: COMPLETED ·Phase: NA
-
PET Evaluation of Recurrent Differentiated Thyroid Cancer
NCT01641679 ·Status: UNKNOWN
-
Evaluating Trends in Anaplastic Thyroid Cancer Patients' Clinical Study Experiences
NCT05819593 ·Status: NOT_YET_RECRUITING
-
Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer
NCT02418247 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Prospective, Observational Study on the Carotid Intima-media Thickness in Patients Undergoing Thyroid Surgery
NCT05774535 ·Status: WITHDRAWN
-
Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients.
NCT05247476 ·Status: UNKNOWN ·Phase: PHASE4
-
Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer
NCT00389441 ·Status: COMPLETED ·Phase: PHASE2
-
Spanish Study for Molecular Characterization of Thyroid Carcinoma
NCT04970134 ·Status: ACTIVE_NOT_RECRUITING
-
Enhancing Radioiodine Incorporation Into Radio Iodine Refractory Thyroid Cancers With MAPK Inhibition
NCT04619316 ·Status: UNKNOWN ·Phase: PHASE2
-
The Prognostic Value of Post Thyroidectomy 99mTCpertechnetate Thyroid Scan in Patient With Differentiated Thyroid Cancer
NCT04563780 ·Status: UNKNOWN
-
Thyroid Dysfunction Induced by Anti-PD-1 Therapy in Patients With Advanced Carcinoma
NCT05593744 ·Status: COMPLETED